Global Antisense and RNAi Therapeutics Sales Market Report 2020 by Manufacturer, Region, Type and Application

Global Antisense and RNAi Therapeutics Sales Market Report 2020 by Manufacturer, Region, Type and Application

Table of Contents

1 Executive Summary

List of Tables and Figures

Figure Product Picture of Antisense and RNAi Therapeutics
Table Product Specifications of Antisense and RNAi Therapeutics
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2020
Table Product Type and Standard
Table Type Overview in 2020
Table Product Application and Standard
Table Application Overview in 2020
Figure Industry Chain Structure of Antisense and RNAi Therapeutics
Table Industry News List of Antisense and RNAi Therapeutics
Table Key Challenges
Table Global Antisense and RNAi Therapeutics Sales (K Units) by Types
Figure Global Antisense and RNAi Therapeutics Sales Market Share (%) by Types in 2014
Figure Global Antisense and RNAi Therapeutics Sales Market Share (%) by Types in 2020
Table RNA interference Sales (K Units) and Growth Rate
Figure RNA interference Sales (K Units) and Growth Rate
Table SiRNA Sales (K Units) and Growth Rate
Figure SiRNA Sales (K Units) and Growth Rate
Table MiRNA Sales (K Units) and Growth Rate
Figure MiRNA Sales (K Units) and Growth Rate
Table Antisense RNA Sales (K Units) and Growth Rate
Figure Antisense RNA Sales (K Units) and Growth Rate
Table Global Antisense and RNAi Therapeutics Revenue (M USD) by Types
Figure Global Antisense and RNAi Therapeutics Revenue Market Share (%) by Types in 2014
Figure Global Antisense and RNAi Therapeutics Revenue Market Share (%) by Types in 2020
Table RNA interference Revenue (M USD) and Growth Rate
Figure RNA interference Revenue (M USD) and Growth Rate
Table SiRNA Revenue (M USD) and Growth Rate
Figure SiRNA Revenue (M USD) and Growth Rate
Table MiRNA Revenue (M USD) and Growth Rate
Figure MiRNA Revenue (M USD) and Growth Rate
Table Antisense RNA Revenue (M USD) and Growth Rate
Figure Antisense RNA Revenue (M USD) and Growth Rate
Table Global Antisense and RNAi Therapeutics Sales (K Units) by Application 2014-2020
Figure Global Antisense and RNAi Therapeutics Sales Market Share (%) by Application in 2014
Figure Global Antisense and RNAi Therapeutics Sales Market Share (%) by Application in 2020
Table Oncology Sales (K Units) and Growth Rate 2014-2020
Figure Oncology Sales (K Units) and Growth Rate 2014-2020
Table Cardiovascular Sales (K Units) and Growth Rate 2014-2020
Figure Cardiovascular Sales (K Units) and Growth Rate 2014-2020
Table Renal Sales (K Units) and Growth Rate 2014-2020
Figure Renal Sales (K Units) and Growth Rate 2014-2020
Table Neurodegenerative Sales (K Units) and Growth Rate 2014-2020
Figure Neurodegenerative Sales (K Units) and Growth Rate 2014-2020
Table Respiratory Sales (K Units) and Growth Rate 2014-2020
Figure Respiratory Sales (K Units) and Growth Rate 2014-2020
Table Genetic Sales (K Units) and Growth Rate 2014-2020
Figure Genetic Sales (K Units) and Growth Rate 2014-2020
Table Infectious Diseases Sales (K Units) and Growth Rate 2014-2020
Figure Infectious Diseases Sales (K Units) and Growth Rate 2014-2020
Table Glaxo Smith Kline Profiles
Table Glaxo Smith Kline Product Information
Table Glaxo Smith Kline Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Glaxo Smith Kline Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Glaxo Smith Kline Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Sanofi Aventis / Genzyme Profiles
Table Sanofi Aventis / Genzyme Product Information
Table Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Sanofi Aventis / Genzyme Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Profiles
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Product Information
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Arbutus Biopharma Ltd. Profiles
Table Arbutus Biopharma Ltd. Product Information
Table Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Arbutus Biopharma Ltd. Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Silence Therapeutics Profiles
Table Silence Therapeutics Product Information
Table Silence Therapeutics Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Silence Therapeutics Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Silence Therapeutics Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Bio-Path Holdings Inc. Profiles
Table Bio-Path Holdings Inc. Product Information
Table Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Bio-Path Holdings Inc. Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Calando Pharmaceuticals Profiles
Table Calando Pharmaceuticals Product Information
Table Calando Pharmaceuticals Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Calando Pharmaceuticals Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Calando Pharmaceuticals Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table ICo Therapeutics Profiles
Table ICo Therapeutics Product Information
Table ICo Therapeutics Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table ICo Therapeutics Antisense and RNAi Therapeutics Sales Change 2014-2020
Table ICo Therapeutics Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Quark Pharmaceuticals Profiles
Table Quark Pharmaceuticals Product Information
Table Quark Pharmaceuticals Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Quark Pharmaceuticals Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Quark Pharmaceuticals Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table Rexhan Pharmaceuticals Profiles
Table Rexhan Pharmaceuticals Product Information
Table Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Sales Change 2014-2020
Table Rexhan Pharmaceuticals Antisense and RNAi Therapeutics Market Status Change 2014-2020
Table …...
Table Global Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table Global Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure Global Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure Global Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table Global Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table Global Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure Global Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure Global Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table Global Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure Global Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure Global Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table Global Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure Global Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure Global Antisense and RNAi Therapeutics Gross Margin in 2020
Figure Global Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table USA Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table USA Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure USA Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure USA Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table USA Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table USA Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure USA Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure USA Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table USA Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure USA Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure USA Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table USA Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure USA Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure USA Antisense and RNAi Therapeutics Gross Margin in 2020
Figure USA Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table Europe Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure Europe Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table Europe Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table Europe Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure Europe Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table Europe Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure Europe Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table Europe Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure Europe Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure Europe Antisense and RNAi Therapeutics Gross Margin in 2020
Figure Europe Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Japan Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table Japan Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure Japan Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure Japan Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table Japan Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table Japan Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure Japan Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure Japan Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table Japan Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure Japan Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure Japan Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table Japan Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure Japan Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure Japan Antisense and RNAi Therapeutics Gross Margin in 2020
Figure Japan Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Korea Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table Korea Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure Korea Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure Korea Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table Korea Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table Korea Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure Korea Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure Korea Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table Korea Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure Korea Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure Korea Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table Korea Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure Korea Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure Korea Antisense and RNAi Therapeutics Gross Margin in 2020
Figure Korea Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table India Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table India Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure India Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure India Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table India Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table India Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure India Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure India Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table India Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure India Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure India Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table India Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure India Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure India Antisense and RNAi Therapeutics Gross Margin in 2020
Figure India Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Southeast Asia Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table Southeast Asia Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure Southeast Asia Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table Southeast Asia Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table Southeast Asia Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure Southeast Asia Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table Southeast Asia Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure Southeast Asia Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure Southeast Asia Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table Southeast Asia Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure Southeast Asia Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure Southeast Asia Antisense and RNAi Therapeutics Gross Margin in 2020
Figure Southeast Asia Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table South America Antisense and RNAi Therapeutics Sales (K Units) of Manufacturers 2014-2020
Table South America Antisense and RNAi Therapeutics Sales Market Share (%) of Manufacturers 2014-2020
Figure South America Antisense and RNAi Therapeutics Sales Market Share (%) in 2014
Figure South America Antisense and RNAi Therapeutics Sales Market Share (%) in 2020
Table South America Antisense and RNAi Therapeutics Revenue (M USD) of Manufacturers 2014-2020
Table South America Antisense and RNAi Therapeutics Revenue Market Share (%) of Manufacturers 2014-2020
Figure South America Antisense and RNAi Therapeutics Revenue Market Share (%) in 2014
Figure South America Antisense and RNAi Therapeutics Revenue Market Share (%) in 2020
Table South America Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers 2014-2020
Figure South America Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2014
Figure South America Antisense and RNAi Therapeutics Price (USD/Unit) of Manufacturers in 2020
Table South America Antisense and RNAi Therapeutics Gross Margin of Manufacturers 2014-2020
Figure South America Antisense and RNAi Therapeutics Gross Margin of Manufacturers in 2014
Figure South America Antisense and RNAi Therapeutics Gross Margin in 2020
Figure South America Antisense and RNAi Therapeutics Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Targeted RNA Sequencing Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......

Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......

Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94

According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......

Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......

Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028

Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Market Status and Outlook 2023-2028

Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106

RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......

Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104

Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs